Durata leads
-
Devices & Diagnostics, Hospitals
St. Jude Medical CEO: When it comes to the Durata lead, facts have been very friendly to us
On Wednesday, St. Jude Medical CEO Dan Starks fielded a couple of questions related to […]
-
Devices & Diagnostics, Hospitals
St. Jude Medical likely to face tough questions about FDA warning letter on earnings call
The shoe finally dropped. The U.S. Food and Drug Administration sent a warning letter to […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Devices & Diagnostics, Hospitals
St. Jude Medical’s $1B share buyback is move to shore stock battered over Durata worries
St. Jude Medical (NYSE:STJ) announced Thursday that its board has authorized a $1 billion share […]